Incidence and survival analysis of gastrointestinal stromal tumors in shanghai: A population-based study from 2001 to 2010

Gastroenterology Research and Practice

Volumn 2014, Issue , 2014, Pages

  Lv, Minzhi ^a   Wu, Chunxiao ^b   Zheng, Ying ^b   Zhao, Naiqing ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; CHINA; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; INTESTINE; MAJOR CLINICAL STUDY; MALE; MASCULINITY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PREDICTION; RISK FACTOR; SEX RATIO; STOMACH; TUMOR LOCALIZATION;

EID: 84901020124     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2014/834136     Document Type: Article

References (31)

1. Zhao X., Yue C., Gastrointestinal stromal tumor. Journal of Gastrointestinal Oncology 2012 3 3 189 208
2. Liegl-Atzwanger B., Fletcher J. A., Fletcher C. D. M., Gastrointestinal stromal tumors. Virchows Archiv 2010 456 2 111 127 2-s2.0-77950345223 10.1007/s00428-010-0891-y
3. Trent J. C., Benjamin R. S., New developments in gastrointestinal stromal tumor. Current Opinion in Oncology 2006 18 4 386 395 2-s2.0-33748078755 10.1097/01.cco.0000228747.02660.e2 (Pubitemid 44297252)
4. Demetri G. D., von Mehren M., Antonescu C. R., NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. Journal of the National Comprehensive Cancer Network 2010 supplement 2 S1 S41
5. Miettinen M., Lasota J., Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Archives of Pathology and Laboratory Medicine 2006 130 10 1466 1478 2-s2.0-33749459756 (Pubitemid 44520713)
6. Mostafa R. M., Moustafa Y. M., Hamdy H., Interstitial cells of Cajal, the Maestro in health and disease. World Journal of Gastroenterology 2010 16 26 3239 3248 2-s2.0-77954562134 10.3748/wjg.v16.i26.3239
7. D'Adamo D., Advances in the treatment of gastrointestinal stromal tumor. Advances in Therapy 2009 26 9 826 837 2-s2.0-76749100603 10.1007/s12325-009- 0067-9
8. Nilsson B., Bümming P., Meis-Kindblom J. M., Odén A., Dortok A., Gustavsson B., Sablinska K., Kindblom L.-G., Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden. Cancer 2005 103 4 821 829 2-s2.0-13444270334 10.1002/cncr.20862 (Pubitemid 40216412)
9. Tryggvason G., Gíslason H. G., Magnússon M. K., Jónasson J. G., Gastrointestinal stromal tumors in Iceland, 1990-2003: the Icelandic GIST study, a population-based incidence and pathologic risk stratification study. International Journal of Cancer 2005 117 2 289 293 2-s2.0-25444448316 10.1002/ijc.21167 (Pubitemid 41377450)
10. Goettsch W. G., Bos S. D., Breekveldt-Postma N., Casparie M., Herings R. M. C., Hogendoorn P. C. W., Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study. European Journal of Cancer 2005 41 18 2868 2872 2-s2.0-28244441991 10.1016/j.ejca.2005.09.009 (Pubitemid 41713125)
11. Mucciarini C., Rossi G., Bertolini F., Valli R., Cirilli C., Rashid I., Marcheselli L., Luppi G., Federico M., Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer 2007 7, article 230 2-s2.0-39349085208 10.1186/1471-2407-7-230 (Pubitemid 351260308)
12. Rubió J., Marcos-Gragera R., Ortiz M. R., Miró J., Vilardell L., Gironès J., Hernandez-Yagüe X., Codina-Cazador A., Bernadó L., Izquierdo A., Colomer R., Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain. European Journal of Cancer 2007 43 1 144 148 2-s2.0-33845995075 10.1016/j.ejca.2006.07. 015 (Pubitemid 46054472)
13. Tran T., Davila J. A., El-Serag H. B., The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. American Journal of Gastroenterology 2005 100 1 162 168 2-s2.0-13744263095 10.1111/j.1572-0241.2005.40709.x (Pubitemid 41623284)
14. Monges G., Bisot-Locard S., Blay J.-Y., Bouvier A.-M., Urbieta M., Coindre J.-M., Scoazec J.-Y., The estimated incidence of gastrointestinal stromal tumors in France. Results of PROGIST study conducted among pathologists. Bulletin du Cancer 2010 97 3 E16 E22 2-s2.0-77950358011 10.1684/bdc.2010.1041
15. Gastrointestinal stromal tumors, ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2012 23 7 vii49 vii55 10.1093/annonc/mds088
16. Demetri G. D., Von Mehren M., Blanke C. D., Van Den Abbeele A. D., Eisenberg B., Roberts P. J., Heinrich M. C., Tuveson D. A., Singer S., Janicek M., Fletcher J. A., Silverman S. G., Silberman S. L., Capdeville R., Kiese B., Peng B., Dimitrijevic S., Druker B. J., Corless C., Fletcher C. D. M., Joensuu H., Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. The New England Journal of Medicine 2002 347 7 472 480 2-s2.0-0037103424 10.1056/NEJMoa020461 (Pubitemid 34879334)
17. Blanke C. D., Demetri G. D., Von Mehren M., Heinrich M. C., Eisenberg B., Fletcher J. A., Corless C. L., Fletcher C. D. M., Roberts P. J., Heinz D., Wehre E., Nikolova Z., Joensuu H., Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. Journal of Clinical Oncology 2008 26 4 620 625 2-s2.0-39149123549 10.1200/JCO.2007.13.4403 (Pubitemid 351264357)
18. Verweij J., Casali P. G., Zalcberg J., LeCesne A., Reichardt P., Blay J.-Y., Issels R., Van Oosterom A., Hogendoorn P. C. W., Van Glabbeke M., Bertulli R., Judson I., Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. The Lancet 2004 364 9440 1127 1134 2-s2.0-20844433223 10.1016/S0140-6736(04)17098-0 (Pubitemid 39296599)
19. DeMatteo R. P., Ballman K. V., Antonescu C. R., Maki R. G., Pisters P. W., Demetri G. D., Blackstein M. E., Blanke C. D., von Mehren M., Brennan M. F., Patel S., McCarter M. D., Polikoff J. A., Tan B. R., Owzar K., Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. The Lancet 2009 373 9669 1097 1104 2-s2.0-62849096370 10.1016/S0140-6736(09)60500-6
20. Shanghai Municipal Statistics Bureau, Shanghai Statistical Yearbook 2011 China Statistics Press
21. Ahmad O. B.,. 2005, Age standardization of rates: a new WHO standard
22. Yan B. M., Kaplan G. G., Urbanski S., Nash C. L., Beck P. L., Epidemiology of gastrointestinal stromal tumors in a defined Canadian Health Region: a population-based study. International Journal of Surgical Pathology 2008 16 3 241 250 2-s2.0-45749094617 10.1177/1066896907306967 (Pubitemid 351873723)
23. Cho M.-Y., Sohn J. H., Kim J. M., Kim K.-M., Park Y. S., Kim W. H., Jung J. S., Jung E. S., Jin S.-Y., Kang D. Y., Park J. B., Park H. S., Choi Y. D., Sung S. H., Kim Y.-B., Kim H., Bae Y.-K., Kang M., Chang H. J., Chae Y. S., Lee H. E., Park D. Y., Lee Y. S., Kang Y. K., Kim H. K., Chang H.-K., Hong S. W., Choi Y. H., Shin O., Gu M., Kim Y. W., Kim G., Chang S. J., Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004. Journal of Korean Medical Science 2010 25 6 853 862 2-s2.0-77956400508 10.3346/jkms.2010.25.6.853
24. Chiang N. J., Chen L.-T., Tsai C.-R., The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998-2008: a nation-wide cancer registry-based study. BMC Cancer 2014 14 1 102 10.1186/1471-2407-14-102
25. Miettinen M., Sobin L. H., Lasota J., Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. American Journal of Surgical Pathology 2005 29 1 52 68 2-s2.0-11144284051 10.1097/01.pas.0000146010.92933.de (Pubitemid 40023952)
26. Perez E. A., Livingstone A. S., Franceschi D., Rocha-Lima C., Lee D. J., Hodgson N., Jorda M., Koniaris L. G., Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. Journal of the American College of Surgeons 2006 202 4 623 629 2-s2.0-33645291186 10.1016/j.jamcollsurg.2006.01.002
27. Agaimy A., Wünsch P. H., Hofstaedter F., Blaszyk H., Rümmele P., Gaumann A., Dietmaier W., Hartmann A., Minute Gastric Sclerosing Stromal Tumors (GIST Tumorlets) are common in adults and frequently show c-KIT mutations. American Journal of Surgical Pathology 2007 31 1 113 120 2-s2.0-33845940073 10.1097/01.pas.0000213307.05811.f0 (Pubitemid 46036910)
28. DeMatteo R. P., Lewis J. J., Leung D., Mudan S. S., Woodruff J. M., Brennan M. F., Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Annals of Surgery 2000 231 1 51 58 2-s2.0-0033984319 10.1097/00000658-200001000-00008 (Pubitemid 30043939)
29. Tran T., Davila J. A., El-Serag H. B., The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. American Journal of Gastroenterology 2005 100 1 162 168 2-s2.0-13744263095 10.1111/j.1572-0241.2005.40709.x (Pubitemid 41623284)
30. Call J. W., Walentas C. D., Eickhoff J. C., Scherzer N. J., Survival of gastrointestinal stromal tumor patients in the Imatinib era: life raft group observational registry. BMC Cancer 2012 12 90 2-s2.0-84858304485 10.1186/1471-2407-12-90
31. Miettinen M., Lasota J., Gastrointestinal stromal tumors: pathology and prognosis at different sites. Seminars in Diagnostic Pathology 2006 23 2 70 83 2-s2.0-33750618188 10.1053/j.semdp.2006.09.001 (Pubitemid 44692418)